SCHEMBL13344992

SCHEMBL13344992

COOSc1ccc2c3c(cc([N+](=O)[O-])c2c1)NCC3CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13345012 0.96
SCHEMBL13344978 0.90
SCHEMBL13344968 0.87
SCHEMBL13344963 0.84
SCHEMBL13460619 0.80 TSHR (0.38)
SCHEMBL3568374 0.79 ALDH1A1 (0.37)
SCHEMBL3558765 0.78 VCAM1 (0.41)
SCHEMBL3563974 0.78 CTSB (0.41)
SCHEMBL13345004 0.76 TSHR (0.38)
SCHEMBL3562579 0.75 VCAM1 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7718688-B2 Nitrobenzindoles and their use in cancer therapy AUCKLAND UNISERVICES LIMITED (NZ) 2010-05-18 US disclosed
US-20080119442-A1 as hypoxia-selective drugs and radiosensitizers for cancer therapy; nitroreductase inhibitor; 1-(Chloromethyl)-5,6-dinitro-3-(5,6,7-trimethoxyindol-2-carbonyl)-1,2-dihydro-3H-benzo[e]indole; halogenation of naphthalene derivative followed by hydration and cyclization AUCKLAND UNISERVICES LIMITED (NZ) 2008-05-22 US disclosed